Astrazeneca (AZN) Minority Interest (2009 - 2026)
Astrazeneca (AZN) posted quarterly Minority Interest of $51.0 million for Q1 2026, down 44.57% year-over-year from $92.0 million in Q1 2025, and down 1.92% quarter-over-quarter from $52.0 million in Q4 2025.
Astrazeneca (AZN) Minority Interest (2009 - 2026) Analysis & Trends
Astrazeneca's Minority Interest history runs 18 years deep, the most recent figure standing at $51.0 million for Q1 2026.
- In Q1 2026, Minority Interest fell 44.57% year-over-year to $51.0 million; the TTM figure through Mar 2026 stood at $51.0 million (down 44.57% YoY), while the FY2025 annual figure was $52.0 million, down 38.82% from the prior year.
- Minority Interest for Q1 2026 stood at $51.0 million, down from $52.0 million in the prior quarter.
- The five-year high for Minority Interest was $92.0 million in Q1 2025, with the low at $19.0 million in Q1 2022.
- The 5-year median for Minority Interest is $51.0 million (2026), against an average of $50.2 million.
- The sharpest annual moves came in 2022 and 2024: Minority Interest tumbled 88.1% in 2022, then surged 269.57% in 2024.
- Astrazeneca's Minority Interest stood at $21.0 million in 2022, then climbed by 9.52% to $23.0 million in 2023, then soared by 269.57% to $85.0 million in 2024, then sank by 38.82% to $52.0 million in 2025, then fell by 1.92% to $51.0 million in 2026.
- Business Quant data shows AZN's Minority Interest at $51.0 million in Q1 2026, $52.0 million in Q4 2025, and $83.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.00 Mn |
| Dec 31, 2025 | 52.00 Mn |
| Sep 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 91.00 Mn |
| Mar 31, 2025 | 92.00 Mn |
| Dec 31, 2024 | 85.00 Mn |
| Sep 30, 2024 | 86.00 Mn |
| Jun 30, 2024 | 86.00 Mn |
| Mar 31, 2024 | 56.00 Mn |
| Dec 31, 2023 | 23.00 Mn |
| Sep 30, 2023 | 24.00 Mn |
| Jun 30, 2023 | 24.00 Mn |
| Mar 31, 2023 | 22.00 Mn |
| Dec 31, 2022 | 21.00 Mn |
| Sep 30, 2022 | 20.00 Mn |
| Jun 30, 2022 | 19.00 Mn |
| Mar 31, 2022 | 19.00 Mn |
| Dec 31, 2021 | 19.00 Mn |
| Sep 30, 2021 | 168.00 Mn |
| Jun 30, 2021 | 17.00 Mn |